Your browser doesn't support javascript.
loading
Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.
Iwanski, Jessika; Knapp, Shannon M; Avery, Ryan; Oliva, Isabel; Wong, Raymond K; Runyan, Raymond B; Khalpey, Zain.
Afiliação
  • Iwanski J; Department of Medical Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.
  • Knapp SM; BIO5 Institute, Statistics Consulting Lab, University of Arizona, Tucson, AZ, USA.
  • Avery R; Department of Nuclear Medicine, Banner University Medical Center, Medical Imaging, Tucson, AZ, USA.
  • Oliva I; Department of Nuclear Medicine, Banner University Medical Center, Medical Imaging, Tucson, AZ, USA.
  • Wong RK; Department of Medical Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA.
  • Runyan RB; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ, USA.
  • Khalpey Z; Department of Medical Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA. zkhalpey@surgery.arizona.edu.
J Cardiothorac Surg ; 12(1): 37, 2017 May 19.
Article em En | MEDLINE | ID: mdl-28526044
ABSTRACT

INTRODUCTION:

Randomized and nonrandomized clinical trials have tried to assess whether or not TMR patients experience an increase in myocardial perfusion. However there have been inconsistencies reported in the literature due to the use of different nuclear imaging modalities to test this metric. The primary purpose of this meta-analysis was to determine whether SPECT, MUGA and PET scans demonstrate changes in myocardial perfusion between lased and non-lased subjects and whether laser type affects myocardial perfusion. The secondary purpose was to examine the overall effect of laser therapy on clinical outcomes including survival, hospital re-admission and angina reduction.

METHODS:

Sixteen studies were included in the primary endpoint analysis after excluding all other non-imaging TMR papers. Standardized mean difference was used as the effect size for all quantitative outcomes and log odds ratio was used as the effect size for all binary outcomes.

RESULTS:

Statistically significant improvements in myocardial perfusion were observed between control and treatment groups in myocardial perfusion at 6-month follow up using PET imaging with a porcine model. However non-significant differences were observed in patients at 3 and 12 months using SPECT, PET or MUGA scans. Both CO2 and HoYAG laser systems demonstrated an increase in myocardial perfusion however this effect was not statistically significant. In addition both laser types displayed statistically significant decreases in patient angina at 3, 6 and 12 months but non-significant increases in survival rates and decreases in hospital re-admissions.

CONCLUSION:

In order to properly assess myocardial perfusion in TMR subjects, subendocardial perfusion needs to be analyzed via nuclear imaging. PET scans can provide this level of sensitivity and should be utilized in future studies to monitor and detect perfusion changes in lased and non-lased subjects.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Perfusão / Doença da Artéria Coronariana / Tomografia por Emissão de Pósitrons / Revascularização Transmiocárdica a Laser Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Perfusão / Doença da Artéria Coronariana / Tomografia por Emissão de Pósitrons / Revascularização Transmiocárdica a Laser Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article